These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1693806)
1. Thyrotropin results in euthyroid patients with a past history of hyperthyroidism. Brownlie BE; Legge HM Acta Endocrinol (Copenh); 1990 May; 122(5):623-7. PubMed ID: 1693806 [TBL] [Abstract][Full Text] [Related]
2. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease. Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE; Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913 [TBL] [Abstract][Full Text] [Related]
3. Excess Mortality in Treated and Untreated Hyperthyroidism Is Related to Cumulative Periods of Low Serum TSH. Lillevang-Johansen M; Abrahamsen B; Jørgensen HL; Brix TH; Hegedüs L J Clin Endocrinol Metab; 2017 Jul; 102(7):2301-2309. PubMed ID: 28368540 [TBL] [Abstract][Full Text] [Related]
4. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs. Buerklin EM; Schimmel M; Utiger RD J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. Bayer MF; Kriss JP; McDougall IR J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528 [TBL] [Abstract][Full Text] [Related]
6. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism. Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562 [TBL] [Abstract][Full Text] [Related]
7. The significance of subnormal, detectable TSH values: laboratory and clinical aspects. Chosich N; LeGrand BA; Topliss DJ; Stockigt JR Thyroidology; 1989 Aug; 1(2):79-83. PubMed ID: 2484867 [TBL] [Abstract][Full Text] [Related]
8. Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine. Hoermann R; Quadbeck B; Roggenbuck U; Szabolcs I; Pfeilschifter J; Meng W; Reschke K; Hackenberg K; Dettmann J; Prehn B; Hirche H; Mann K; Thyroid; 2002 Dec; 12(12):1119-28. PubMed ID: 12593726 [TBL] [Abstract][Full Text] [Related]
9. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients. Brokken LJ; Wiersinga WM; Prummel MF J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276 [TBL] [Abstract][Full Text] [Related]
10. Screening of geriatric patients for thyroid dysfunction with thyrotropin-releasing-hormone test, sensitive thyrotropin and free thyroxine estimation. Szabolcs I; Ploenes C; Bernard W; Herrmann J Horm Metab Res; 1990 May; 22(5):298-302. PubMed ID: 2112111 [TBL] [Abstract][Full Text] [Related]
11. [Diminution of thyroid stimulating hormone level but normal levels of thyroid hormones. Demonstration of occult hyperthyroidism]. Schlienger JL; Klerlein M; Sapin R; Demangeat JL; Imler M Presse Med; 1989 Apr; 18(14):707-10. PubMed ID: 2471184 [TBL] [Abstract][Full Text] [Related]
12. The importance of elevated TSH in serum after subtotal thyroidectomy for hyperthyroidism. A five-year follow-up study. Lundström B; Gillquist J Acta Chir Scand; 1981; 147(8):645-7. PubMed ID: 7344384 [TBL] [Abstract][Full Text] [Related]
13. [Comparative studies on the behavior of thyroid hormone levels and TSH level in the TRH-test in the course of experimental and thyreostatically treated hyperthyroidism]. Hartmann KP; Henderkott U; Hör G; Bottermann P Verh Dtsch Ges Inn Med; 1975; 81():1559-63. PubMed ID: 58496 [No Abstract] [Full Text] [Related]
14. Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy? Tigas S; Idiculla J; Beckett G; Toft A Thyroid; 2000 Dec; 10(12):1107-11. PubMed ID: 11201857 [TBL] [Abstract][Full Text] [Related]
15. Assessment of sensitive thyrotropin assays for an expanded role in thyroid function testing: proposed criteria for analytic performance and clinical utility. Klee GG; Hay ID J Clin Endocrinol Metab; 1987 Mar; 64(3):461-71. PubMed ID: 3102536 [TBL] [Abstract][Full Text] [Related]
16. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents. Wood LC; Ingbar SH J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625 [TBL] [Abstract][Full Text] [Related]
17. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy. Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234 [TBL] [Abstract][Full Text] [Related]
18. Subtotal thyroidectomy for thyrotoxicosis: a reassessment, including TRH responsiveness. Chambers S; Brownlie BE; Turner JG; Macbeth WA N Z Med J; 1978 Mar; 87(607):163-6. PubMed ID: 418367 [TBL] [Abstract][Full Text] [Related]
19. Results of treatment of thyrotoxicosis after postoperative relapse. McLarty DG; Alexander WD; Harden RM; Clark DH Br Med J; 1969 Jul; 3(5664):200-3. PubMed ID: 4183089 [TBL] [Abstract][Full Text] [Related]
20. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Sawin CT; Geller A; Kaplan MM; Bacharach P; Wilson PW; Hershman JM Arch Intern Med; 1991 Jan; 151(1):165-8. PubMed ID: 1985591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]